drugset / Trial / NCT01521819
Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration
NaSingle-groupOpen-labelTreatment
Summary
This is a pilot, single-center, interventional clinical trial in which subjects will receive 16 Gy of IRay treatment and Lucentis, followed by Lucentis treatment as needed.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Ranibizumab | Monoclonal antibody | — | Intravitreal |